Risk of adverse pregnancy outcomes in women treated for malaria with dihydroartemisinin-piperaquine or quinine in the first trimester of pregnancy in Indonesia: a retrospective data analysis

Lignende værker

• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
  af: Poespoprodjo, JR, et al.
  Udgivet: (2014)
• Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
  af: Jeanne Rini Poespoprodjo, et al.
  Udgivet: (2014-01-01)
• Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
  af: Poespoprodjo, J, et al.
  Udgivet: (2015)
• Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy
  af: Chotsiri, P, et al.
  Udgivet: (2021)
• Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
  af: Ahmed, R, et al.
  Udgivet: (2019)